SUBSCRIBE NOW! - Incontact magazine comes out 3 times a year and contains the latest news, product information, advice from healthcare professionals, letters and in depth features about coping with a bladder or bowel problem. A subscription costs just £10 a year or £5 if you are on benefits! Please call us for more information on 0870 770 3246.
Home
About Incontact
Who we can help
Ask an Expert
Treatment review
News
Facts & Products
Publications
Diverticular Disease
Subscription Page
Professional Support
Support Network
Message Forum
Chat Room
You can help
Contact us
Links
Search
Terms and Conditions
Corporate Supporters
 
 
Chat
Thursday 8.30pm
Young people under 35
Host: Joanne
Fact File
Make me Laugh
An overview of stress incontinence
 
 
Search
 

Injectables for the treatment of bladder and bowel problems

The injection of bulking agents around the urethra or bowel sphincter as a treatment for some bladder and bowel problems has aroused a great deal of interest. Here we find out more.

Bladder problems

The ability of the bladder and urethra to prevent leakage of urine during coughing, sneezing and exercise appears to rely on two different mechanisms. The first is the support of the bladder and urethra by the pelvic floor muscles, and the ligaments and connective tissues surrounding the bladder base. These help to provide support during times of physical exertion and may be damaged during pregnancy and childbirth, or weakened by age or heavy exercise, leading to the development of stress incontinence.

The second mechanism preventing leakage of urine is the watertight seal provided by the urethra itself. This may also be damaged or weakened by pregnancy, childbirth and ageing, or damaged by scarring from surgery or radiotherapy.

Physiotherapy acts to increase the strength and support given by the pelvic floor muscles. Most surgical operations for stress incontinence are based on lifting and re-supporting the bladder and urethra. Operations such as colposuspension, "sling" procedures and vaginal repair are all designed to work mainly in this way.

The injection of materials close to the urethra and its opening into the bladder provide pressure to help restore the seal of the urethra and help it stay watertight. This is not a new idea - almost a hundred years ago an injection of phenol, an irritant, was tried. The resulting scarring may have helped narrow the urethra and cured some women, but the high complication rate meant that this technique was quickly abandoned.

More recently, a number of different substances have been used, much more successfully.

Fat, removed from beneath the woman's own skin may be used for injection. It is cheap and easy to obtain and, as it comes from the woman herself, there is no worry about infection. Unfortunately, the results appear very short lasting, the fat cells quickly disperse and, for this reason, this technique is rarely employed.

Collagen (GAX collagen, Contigen) has been widely used for a number of years. It is produced from the cartilage of cattle from the USA, which is extensively processed and sterilised to produce a viscous paste. There is no risk of Bovine Spongiform Encephalopathy (BSE) transmission due to the processing which would destroy any bacterial or viral particles.

A paste made from microscopic particles of silicone suspended in a viscous gel (Macroplastique) is also currently used, and a number of new products have recently become available (e.g. URYX, Permacol, Coaptite).

Injection of all the periurethral bulking agents is performed in a similar way. The procedure is quick, taking 15 to 20 minutes. No incisions are made and this means that it may be carried out with local anaesthetic or under a regional anaesthetic such as an epidural. Using a fine fiberoptic cystoscope the inside of the urethra and bladder can be inspected, and a fine needle guided to inject the material at exactly the appropriate spot. Usually three injections are made around the urethra. The exact amount used depends on the material used and how much closure of the urethra the surgeon feels is required.

As the operation is short and there is little discomfort afterwards it is possible for women to go home the same day. Some units prefer women to stay overnight to check that there are no problems with bladder emptying. Either way, recovery from the operation is very quick.

Given that this technique is so quick and easy, with very few complications, it would appear to be an ideal treatment for stress incontinence. Unfortunately, the problem lies with the longer-term results. In the short term, within three months after injection, the results are good with at least 80% of women cured or improved. As time goes on, however, the results become poorer. After two years, less than half of these women will still be cured. This is due to the material injected dispersing away from the urethra over time.

It is not clear at this time which material is longest lasting: fat seems to be absorbed very quickly, GAX collagen and Macroplastique persist for much longer. Newer materials under development may improve these results. A recent study comparing URYX and Contigen suggested that women treated with URYX were drier after one year than those treated with Contigen.

The poorer long-term effects of periurethral injections do not mean that they are not suitable for some women, however. As the operation is relatively minor, it may suit older women who are less fit for more complicated surgery. The long-term results in older women who are less physically active also tend to be much better.

One study found that some younger women opt for injections because they do not want a lengthy convalescence period, either keeping them off work or preventing them caring for their small children. In both situations, they said they would prefer a less debilitating treatment even if regular top-ups are required.

Bowel problems

It is estimated that 2.2% of the population is affected with faecal incontinence, with approximately 10% of these aged over 65. This condition has a devastating impact on the social and psychological wellbeing of those affected.

The internal anal sphincter is the main muscle that helps prevent faecal leakage. Childbirth and surgery (such as sphincterotomy or fistula surgery) can cause damage to the internal anal sphincter, which can lead to leakage. The internal sphincter is not easy to repair as it is extremely thin and, as a circular muscle, is under tension. While antidiarrhoeal drugs such as loperamide or codeine phosphate help some patients, this may not be an adequate long-term solution.

Uroplasty has recently developed PTP Implants that are specifically designed for this problem. These involve an injection of a tissue-bulking agent into the internal anal sphincter. The procedure only takes a few minutes, performed in the hospital or clinic under local or general anaesthetic, with the patient usually being discharged home the same day.

Some of the procedures outlined here are relatively new, with little evidence as to how well they work. They may not be the ideal treatment for everyone, and there are still risks involved. For more information about any of the procedures outlined here, talk to your doctor or continence advisor.


Back to Information Sheets

 

 
 
 
Latest News
Featured Publications
 
 
Incontact gratefully acknowledges its Corporate Partners: